Evidence map›Paper›PMID 29182594›Full record

ArticleInternational journal of molecular sciences2017

Pharmacokinetics of Chlorin e₆-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma.

Arthur B Volovetsky, Vladimir S Sukhov, Irina V Balalaeva, Varvara V Dudenkova, Natalia Yu Shilyagina, Аlexey V Feofanov, Anastasija V Efremenko, Mikhail A Grin, Andrey F Mironov, Igor B Sivaev and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Cobalt Bis-Dicarbollide Enhances Antibiotics Action towardsPharmaceuticals (Basel, Switzerland) · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Arthur B VolovetskyDepartment of Biophysics, Lobachevsky State University of Nizhny Novgorod, 23 Gagarina Av., 603950 Nizhny Novgorod, Russia. voloveckiy91@gmail.com.
Vladimir S SukhovDepartment of Biophysics, Lobachevsky State University of Nizhny Novgorod, 23 Gagarina Av., 603950 Nizhny Novgorod, Russia. vssuh@mail.ru.ORCID 0000-0002-8712-9127
Irina V BalalaevaDepartment of Biophysics, Lobachevsky State University of Nizhny Novgorod, 23 Gagarina Av., 603950 Nizhny Novgorod, Russia. irin-b@mail.ru.
Varvara V DudenkovaDepartment of Biophysics, Lobachevsky State University of Nizhny Novgorod, 23 Gagarina Av., 603950 Nizhny Novgorod, Russia. orannge@mail.ru.
Natalia Yu ShilyaginaDepartment of Biophysics, Lobachevsky State University of Nizhny Novgorod, 23 Gagarina Av., 603950 Nizhny Novgorod, Russia. nat-lekanova@yandex.ru.
Аlexey V FeofanovShemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya Str., 117997 Moscow, Russia. avfeofanov@yandex.ru.
Anastasija V EfremenkoShemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya Str., 117997 Moscow, Russia. aefr@mail.ru.
Mikhail A GrinInstitute of Fine Chemical Technology, Moscow Technological University, 86 Vernadskii Av., 119571 Moscow, Russia. michael_grin@mail.ru.
Andrey F MironovInstitute of Fine Chemical Technology, Moscow Technological University, 86 Vernadskii Av., 119571 Moscow, Russia. mironov@mitht.ru.
Igor B SivaevNesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, 28 Vavilov Str., 119991 Moscow, Russia. sivaev@ineos.ac.ru.ORCID 0000-0002-5442-367X
Vladimir I BregadzeNesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, 28 Vavilov Str., 119991 Moscow, Russia. bre@ineos.ac.ru.
Anna V MaslennikovaDepartment of Biophysics, Lobachevsky State University of Nizhny Novgorod, 23 Gagarina Av., 603950 Nizhny Novgorod, Russia. maslennikova.anna@gmail.com.
N. I. Lobachevsky State University of Nizhny Novgorod · RUA. N. Nesmeyanov Institute of Organoelement Compounds · RULomonosov Moscow State University · RUMoscow State University of Fine Chemical Technologies · RUPrivolzhsky Research Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The necessary precondition for efficient boron neutron capture therapy (BNCT) is control over the content of isotope

Indexed as

AnimalsBoronBoron Neutron Capture TherapyCarcinomaCell Line, TumorCobaltFemaleMiceMice, Inbred BALB CMicroscopy, FluorescencePhotochemotherapyPhotosensitizing AgentsPorphyrinsBoronchlorinCobaltPhotosensitizing AgentsPorphyrinsboron contentboron neutron capture therapychlorin e6 derivativesfluorescent microscopyMS-ICPsimple multichamber model

Identifiers

PMID29182594
PMCPMC5751159
OpenAlexW2768819321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.